Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Cancers|June 11, 2020
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 TranslocationsKathy-Ann Secker, Lukas Bruns, Hildegard Keppeler, et al.
International Journal of Molecular Sciences|December 17, 2024
Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by VolasertibJacqueline Fischer, Estelle Erkner, Pia Radszuweit, et al.
Cancers|May 28, 2020
MAT2A as Key Regulator and Therapeutic Target in MLLr LeukemogenesisKathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, et al.
Oncogene|August 17, 2019
Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9Kathy-Ann Secker, Hildegard Keppeler, Silke Duerr-Stoerzer, et al.
Blood|April 19, 2017
Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cellsJing Du, Katelyn Paz, Govindarajan Thangavelu, et al.
Arthritis Research & Therapy|April 2, 2020
Inhibition of effector B cells by ibrutinib in systemic sclerosisJakob Einhaus, Ann-Christin Pecher, Elisa Asteriti, et al.
Haematologica|January 14, 2021
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cellsHannes Schmid, Emmanuelle M Ribeiro, Kathy-Ann Secker, et al.
Transplantation and Cellular Therapy|May 17, 2022
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell TransplantationDominik Schneidawind, Silke Duerr-Stoerzer, Sonja Liewer, et al.
Annals of Hematology|July 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patientsSebastian M Stolz, Albulena Musa, Adrian Bachofner, et al.
Neoplasia (New York, N.Y.)|May 6, 2023
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunityRahel Fitzel, Kathy-Ann Secker-Grob, Hildegard Keppeler, et al.
Pageof 6